Brief: Prostatype Genomics Presents Business Plan For US Market

Prostatype Genomics AB

28/10/2024 07:32

Oct 28 (Reuters) - Prostatype Genomics AB  PROGEN.ST :
    * PROSTATYPE GENOMICS PRESENTS BUSINESS PLAN FOR US MARKET
VALUED
AT 6 BILLION SEK (600 MILLION USD) PER YEAR
    * IN 2025, PROVEN SCALABILITY IN US MARKET IS DEEMED TO BE
MOST
VALUE-DRIVING MILESTONE
    * EXPECTS TO REACH BREAKEVEN IN Q4 2026 FOLLOWED BY
PROFITABLE
GROWTH AND ATTRACTIVE PROFIT MARGIN

Source text:  ID:nMFN52DtC 
Further company coverage:  PROGEN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))